Anti-obesity medications: gastrointestinal adverse events common

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2025年 / 2046卷 / 1期
关键词：
D O I：
10.1007/s40278-025-77390-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication
    Choi, Yeo Jin
    Choi, Chang-Young
    Kim, Choong Ui
    Shin, Sooyoung
    JOURNAL OF GLOBAL HEALTH, 2023, 13
  • [22] Evaluation of GPT-4 for Common Questions Regarding Anti-Obesity Medications: A Comparative Analysis
    Fredrick, Thomas
    Aggarwal, Manik
    Acosta, Andres
    OBESITY, 2024, 32 : 28 - 28
  • [23] Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity
    Chetty, Ashwin K.
    Khunte, Mihir
    Chen, Alissa S.
    Jastreboff, Ania M.
    Krumholz, Harlan M.
    Lu, Yuan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024,
  • [24] Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy
    Kabiri, Mina
    Ward, Alison Sexton
    Ramasamy, Abhilasha
    Kee, Rebecca
    Ganguly, Rahul
    Smolarz, Brian Gabriel
    Zvenyach, Tracy
    Baumgardner, James R.
    Goldman, Dana P.
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [25] A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications
    Huang, Pan-feng
    Wang, Qi-Yu
    Chen, Rong-Bin
    Wang, Ya-Di
    Wang, Yuan-Yuan
    Liu, Jiang-Hua
    Xiao, Xin-Hua
    Liao, Zhe-Zhen
    CURRENT MOLECULAR MEDICINE, 2025, 25 (01) : 13 - 26
  • [26] Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications
    Onakpoya, I.
    Heneghan, C.
    Aronson, J.
    DRUG SAFETY, 2015, 38 (10) : 1016 - 1017
  • [27] Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database
    Yang, Qing
    Wang, Junyan
    Wang, Menghuan
    Zhang, Shuyu
    He, Qin-Qin
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
  • [28] PARENTAL OPINIONS OF ANTI-OBESITY MEDICATIONS FOR PEDIATRIC OBESITY AND CO-MORBIDITIES
    Hasan, Anam
    Raatz, Sarah
    Freese, Rebecca
    Bensignor, Megan
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 276 - 277
  • [29] ANTI-OBESITY MEDICATIONS ARE UNDERUTILIZED IN TERTIARY ACADEMIC NAFLD CLINIC
    Petrie, Erin
    Aryan, Mahmoud
    Ousley, Robert
    Massoud, Moustafa
    Ravi, Sujan
    Beasley, Mark
    Shoreibah, Mohamed
    Gray, Meagan
    GASTROENTEROLOGY, 2022, 162 (07) : S1272 - S1272
  • [30] Why are we still in need for novel anti-obesity medications?
    Novikoff, Aaron
    Grandl, Gerald
    Liu, Xue
    Mueller, Timo D.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
12345